22nd Century Group has sold GVB Biopharma to Specialty Acquisition Corporation
Client: 22nd Century Group
Client Location: United States
Target: GVB Biopharma
Target Location: United States
Acquirer: Speciality Acquisition Corporation
Acquirer Location: United States
Target Description: GVB grows, manufactures and processes hemp cannabinoid products.
Meet our Senior Team
I enhance my clients’ decision making and governance processes by providing independent and objective financial advice in a highly responsive manner.
Chris Gregory
Managing Director & Co-head of Transaction Opinions
New YorkView More Transactions in Valuations & Opinions
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.